Form 4: Kura Oncology Executive Sells Shares
Insider Transaction (Form 4)
Teresa Brophy Bair, Chief Legal Officer of Kura Oncology, Inc., sold 31,487 shares of common stock on August 19, 2026 for $12.63 per share.
Summary
- Open-market sale: disposed of 31,487 Common Stock at $12.63 ($397,681) on August 19, 2026; holds 195,444 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $397,681 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Teresa Brophy Bair — Officer (Chief Legal Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Open-market sale | Common Stock | 31,487 | $13 | $397.7K | 195,444 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Open-market sale (31,487 shares) |
Keywords
insider transaction, Form 4, KURA, Kura Oncology, Inc., bearish, Teresa Brophy Bair
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.